Ex-Rep. Cantor to lead pharma lobbying amid bipartisan cost backlash

Former House Majority Leader Eric Cantor is reportedly set to take a leadership role in pharmaceutical industry lobbying in Washington, facing bipartisan pressure over rising healthcare costs. The move signals the industry's attempt to leverage Republican connections, but its effectiveness is uncertain given the broad political consensus on drug pricing.